Anagnostics Using Scienion Technology for Sepsis Test Products | GenomeWeb

NEW YORK (GenomeWeb News) – Scienion and Anagnostics Bioanalysis today said that Anagnostics is using Scienion's SciFlexArrayer in the production of Anagnostics' new products focused on integrating sepsis testing.

Anagnostics, based in St. Valentin, Austria, develops systems and tests for multiplex diagnostics. Its hybcell technology is a microarray based on cylinders instead of slides. Hybcells are automatically processed by the company's fully integrated and automated single device system for multiplexed diagnostics called hyborgs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.